Brief: Liminatus Pharma Enters Settlement Agreement With Clear Street LLC
09/02/2026 20:06
Feb 9 (Reuters) - Liminatus Pharma Inc LIMN.O: LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILING LIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminatus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock
Brief: Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody
Brief: Liminatus Pharma Enters Settlement Agreement With Clear Street LLC